News No US Remicade biosimilar until at least October Pfizer must wait until 180 day period ends, court fight ongoing.
Clinical Sandoz biosimilar trial hailed as 'landmark' Patients switched between the originator and the near-copy.
News Biosimilars don't need big market share to bring savings - I... Competition can also drive down price of entire drug class.
News US regulatory advisers to review Amgen's Humira biosimilar World's biggest selling drug could face competition.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
